ArticleOncotarget2017

Therapeutically blocking Interleukin-11 Receptor-α enhances doxorubicin cytotoxicity in high grade type I endometrioid tumours.

Amy Winship et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.